Cetera Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$5.02M	Buy	5,218 +2,781	+114%	+$2.64M	0.04%	459
2023 Q4	$2.14M	Buy	2,437 +72	+3%	+$59.3K	0.03%	479
2023 Q3	$1.95M	Buy	2,365 +3	+0.1%	+$2.36K	0.03%	474
2023 Q2	$1.7M	Buy	2,362 +175	+8%	+$135K	0.03%	519
2023 Q1	$1.8M	Buy	2,187 +8	+0.4%	+$6.03K	0.03%	486
2022 Q4	$1.57M	Buy	2,179 +298	+16%	+$220K	0.03%	515
2022 Q3	$1.3M	Sell	1,881 -222	-11%	-$140K	0.03%	459
2022 Q2	$1.24M	Buy	2,103 +124	+6%	+$80.6K	0.03%	503
2022 Q1	$1.38M	Buy	1,979 +56	+3%	+$35.4K	0.03%	507
2021 Q4	$1.21M	Sell	1,923 -45	-2%	-$27.7K	0.02%	532
2021 Q3	$1.19M	Buy	1,968 +164	+9%	+$102K	0.02%	550
2021 Q2	$1.01M	Sell	1,804 -10	-0.6%	-$5.07K	0.02%	542
2021 Q1	$858K	Buy	1,814 +399	+28%	+$194K	0.02%	540
2020 Q4	$684K	Buy	1,415 +880	+164%	+$475K	0.02%	529
2020 Q3	$299K	Sell	535 -274	-34%	-$166K	0.01%	728
2020 Q2	$505K	Sell	809 -630	-44%	-$358K	0.02%	530
2020 Q1	$703K	Buy	+1,439	New	+$594K	0.04%	383
2018 Q4	–	Sell	-952	Closed	-$382K	–	943
2018 Q3	$382K	Buy	+952	New	+$362K	0.02%	652
2015 Q4	–	Sell	-743	Closed	-$347K	–	760
2015 Q3	$347K	Buy	743 +50	+7%	+$26.9K	0.03%	450
2015 Q2	$359K	Sell	693 -2	-0.3%	-$976	0.03%	459
2015 Q1	$316K	Buy	695 +180	+35%	+$76.3K	0.03%	490
2014 Q4	$211K	Buy	+515	New	+$203K	0.02%	587
2013 Q4	–	Sell	-670	Closed	-$210K	–	521
2013 Q3	$210K	Buy	+670	New	+$176K	0.04%	398